MIP Discovery
Life Sciences • • Growth
MIP Discovery develops and manufactures nanoMIPs, linear MIPs, bulk MIP and Rationally Designed Polymers using its proprietary processes.
Molecularly Imprinted Polymers (MIPs) are ‘synthetic’ affinity reagents and the nanoMIP format provides a more robust alternative to antibodies, typically with similar or greater affinity coupled with additional unique characteristics.
The company was previously known as MIP Diagnostics.
Company
information
Total BGF investment
£2 million
Investment date
Jul 2020
Head office
Bedfordshire
Chair
Jim Reid